Upregulation of TLRs and IL-6 as a Marker in Human Colorectal Cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Upregulation of TLRs and IL-6 as a Marker in Human Colorectal Cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 16, Issue 1, Pages 159-177
Publisher
MDPI AG
Online
2014-12-25
DOI
10.3390/ijms16010159
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Expression of Toll-like Receptor 8 and Its Relationship with VEGF and Bcl-2 in Cervical Cancer
- (2014) Yun Zhang et al. International Journal of Medical Sciences
- In silico and Ex vivo approaches identify a role for toll-like receptor 4 in colorectal cancer
- (2014) Daniel A Sussman et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Toll-like Receptor 4 Variant D299G Induces Features of Neoplastic Progression in Caco-2 Intestinal Cells and Is Associated With Advanced Human Colon Cancer
- (2011) Annette Eyking et al. GASTROENTEROLOGY
- Stromal cell-derived factor-1/CXC receptor 4 and β1 integrin interaction regulates urokinase-type plasminogen activator expression in human colorectal cancer cells
- (2011) Wen-Shih Huang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Effects of TLR agonists on maturation and function of 3-day dendritic cells from AML patients in complete remission
- (2011) Barbara Beck et al. Journal of Translational Medicine
- Baicalein inhibits the migration and invasive properties of human hepatoma cells
- (2011) Yung-Wei Chiu et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer
- (2010) E L Wang et al. BRITISH JOURNAL OF CANCER
- Toll-like receptor (TLR) 7 and TLR8 expression on CD133+ cells in colorectal cancer points to a specific role for inflammation-induced TLRs in tumourigenesis and tumour progression
- (2010) Martin Grimm et al. EUROPEAN JOURNAL OF CANCER
- Antitumor Activity and Immune Response Induction of a Dual Agonist of Toll-Like Receptors 7 and 8
- (2010) D. Wang et al. MOLECULAR CANCER THERAPEUTICS
- TLR8 agonists stimulate newly recruited monocyte-derived cells into potent APCs that enhance HBsAg immunogenicity
- (2010) Jun Du et al. VACCINE
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors
- (2009) Masayuki Fukata et al. INFLAMMATORY BOWEL DISEASES
- The Interleukin-8 Pathway in Cancer
- (2008) D. J.J. Waugh et al. CLINICAL CANCER RESEARCH
- TLR7 and TLR8 as targets in cancer therapy
- (2008) M P Schön et al. ONCOGENE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started